From the Concordia Sanatorium and the Concordia Chamber of Clinics and Sanatoriums that brings together the five providers who have hospitalization, they highlight a critical situation due to the economic situation of the country and the lack of updates.
Concordia Sanatorium.jpg
Complaint in Concordia for tariffs.
Andrés Lemesoff is the president of the board of directors and commented that for the first time the three legs of private health financing are at a crossroads. “We are in a very particular situation not only with Pami, but also with Iosper and the prepaid medicine companies have joined this particular situation. It is a quite complex panorama, I am not saying dark but gray at least,” he admitted.
The doctor indicated that they have made various notes with Pami but that they have not received any response. “As of today, all hospitalizations and all services are being carried out normally. I estimate that between now and Monday we have to have some news. The claim is of an economic nature, basically the accumulated inflation from January to May is around 60 percent, May has already started and will be around another 8, 9 or 10 percent, that is, we are talking about 70% because in May we continue working with the institute and the tariff update that Pami has given has been 20% in January and 12.5 percent in March. With the addition that it is charged 60 and 80 days after the service is provided. This has generated an almost total defunding of our institution. Despite having had meetings with the new management of the local UGL, a month has passed and the truth is that we have not had any type of response,” he listed.
And he added: “The National State requires prepaid medicine companies to increase the fees to their members with the index and the consumer price and on the other hand, Pami does not adapt to that, it does not increase the tariffs according to the index. of consumer price. There is a double standard that is handled on the same desk that is difficult to understand. On the one hand they ask for one thing and on the other hand they give another or they do not give with the same equity.”
From the sector they pointed out that if there is no agreement, the service could be cut off or a partial restriction thereof. “The last thing we want to end up with is not being able to provide something in the activity we do,” he said.
Lemesoff also emphasized the costs they must face, both with input inflation and employee parity. “It is the first time in at least the last five or six years that it has happened that the percentage of the joint venture is higher than the increase of a financier, in this case Pami. The updating of tariffs has always gone hand in hand with parity agreements and hand in hand with inflation, but in the last four months this has become outdated,” he said.
For his part, the doctor specified how the national government’s recent decision not to increase tariffs influences. “It is influenced by the fact that the increases agreed in the month of April have been cancelled, that also makes the financing of the institutions difficult, but it is also understandable that the fees of the prepaid medicine companies have become impossible to pay or have reached a cost which is very high in proportion to salaries. The issue is quite broad. I am not a specialist in the prepaid medicine part, but there was also a delay in the last three years between the pandemic and the last year of the previous government, where they were. The quotas ‘stepped’ to put it in some way. There is a situation where you need to have the costs established, but a quota cannot take you 50% of your salary either,” he expressed.
Finally, Lemesoff specified the status of the relationship with Iosper. “We have a very good relationship, we have a constant dialogue. We have no problems with collections, it is paid in a timely manner, the problem that exists with Iosper is the historically low tariffs. It is not something current, it is something that is coming dragging on for several years, where the value of the benefit is low. But so far we have not had any type of problem and we have agreed on a hearing with the Iosper board for the month of May,” he admitted and in closing he noted: “Never. “It turned out that with all the financiers there are situations, each one is special, but they are ultimately situations that complicate day-to-day life.”
